Drug
Tumor Infiltrating Lymphocytes
Tumor Infiltrating Lymphocytes: highest development phase Phase 1, developed by United Therapeutics. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- United Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| Tumor-infiltrating Lymphocytes (TIL) NCT03215810 | Phase 1 | Non-Small Cell Lung Cancer |
Latest
No recent events.
Follow Tumor Infiltrating Lymphocytes on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.